0000950170-23-067149.txt : 20231201
0000950170-23-067149.hdr.sgml : 20231201
20231201080004
ACCESSION NUMBER: 0000950170-23-067149
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231129
FILED AS OF DATE: 20231201
DATE AS OF CHANGE: 20231201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Imran Talat
CENTRAL INDEX KEY: 0001869579
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40672
FILM NUMBER: 231457552
MAIL ADDRESS:
STREET 1: C/O RANI THERAPEUTICS HOLDINGS, INC.
STREET 2: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001856725
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
BUSINESS PHONE: (408) 457-3700
MAIL ADDRESS:
STREET 1: 2051 RINGWOOD AVENUE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
4
1
ownership.xml
4
X0508
4
2023-11-29
0001856725
Rani Therapeutics Holdings, Inc.
RANI
0001869579
Imran Talat
C/O RANI THERAPEUTICS LLC
2051 RINGWOOD AVE.
SAN JOSE
CA
95131
true
true
false
false
Chief Executive Officer
false
Class A Common Stock
2023-11-29
4
P
false
20000
2.05
A
469455
D
Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
/s/ Talat Imran
2023-12-01